Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON
  1. Homepage
  2. Equities
  3. Denmark
  4. Nasdaq Copenhagen
  5. Chr. Hansen Holding A/S
  6. News
  7. Summary
    CHR   DK0060227585

CHR. HANSEN HOLDING A/S

(CHR)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector news

Chr Hansen A/S : Notice to convene the Annual General Meeting 2020

10/29/2020 | 05:15am EDT
Notice to convene the Annual General Meeting 2020

Company announcement no. 25

The Annual General Meeting of Chr. Hansen Holding A/S will be held on

Wednesday, November 25, 2020 at 4:00 p.m. CET

at Søhuset Konferencecenter, Venlighedsvej 10, 2970 Hørsholm, Denmark.

The notice to convene the Annual General Meeting, including annex 1 'Description of the candidates for the Board of Directors', is enclosed.

Important notice in relation to the COVID-19 pandemic
In order to protect the health and safety of all and given the Danish government's restrictions on assembly, we strongly recommend that shareholders follow the Annual General Meeting via live-stream instead of attending in person, and make use of the possibility to give proxy or vote by correspondence.

Shareholders are encouraged to submit written questions concerning the agenda or the documents, etc. to be considered at the Annual General Meeting at least one week ahead of the meeting, i.e. no later than Wednesday November 18, 2020. Questions can be submitted to investorrelations@chr-hansen.com. The Company will aim to answer such questions in writing before the Annual General Meeting.

No refreshments will be served at the Annual General Meeting.

For more information please refer to the 'Important notice in relation to the COVID-19 pandemic' on page 2 of the notice to convene the Annual General meeting.

For further information please contact:

Martin Riise, Senior Director, Investor Relations, Tel: +45 5339 2250
Annika Stern, Investor Relations Officer, Tel: +45 2399 2382
Camilla Lercke, Head of Media Relations, Tel: +45 5339 2384

About Chr. Hansen

Chr. Hansen is a global, differentiated bioscience company that develops natural ingredient solutions for the food, nutritional, pharmaceutical and agricultural industries. At Chr. Hansen we are uniquely positioned to drive positive change through microbial solutions. We have worked for over 145 years to enable sustainable agriculture, cleaner labels and healthier living for more people around the world. Our microbial and fermentation technology platforms, including our broad and relevant collection of around 40,000 microbial strains, have game-changing potential. Matching customer needs and global trends we continue to unlock the power of good bacteria to respond to global challenges such as food waste, global health and the overuse of antibiotics and pesticides. As the world's most sustainable food ingredients company, we touch the lives of more than 1 billion people every day. Driven by our legacy of innovation and curiosity to pioneer science, our purpose - To grow a better world. Naturally. - is at the heart of everything we do.

Attachments

Attachments no-25-notice-to-convene-the-annual-general-meeting-2020.pdf
no-25-annex-1-agm-2020-notice-to-convene.pdf

Disclaimer

Chr. Hansen Holding A/S published this content on 29 October 2020 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 29 October 2020 10:14:07 UTC


ę Publicnow 2020
All news about CHR. HANSEN HOLDING A/S
05/31CHR HANSEN A/Sá : . Hansen JV With Lonza Obtains Manufacturing License In Denmar..
MT
05/31CHR HANSEN A/Sá : Bacthera receives manufacturing licenses in Switzerland and De..
PU
05/31CHR HANSEN A/Sá : . Hansen launches global science-based online platform on prob..
PU
05/18CHR. HANSEN HOLDING A/S : Infrequent or one-off capital gain payment
FA
05/17CHR HANSEN A/Sá : Extraordinary dividend
AQ
05/12CHR HANSEN A/Sá : . Hansen and Nestlé settle court case about Human Milk Oligosa..
PU
05/11CHR HANSEN A/Sá : Sustainability roadshow presentation (May 2021)
PU
05/11CHR HANSEN A/Sá : . Hansen launches VEGA™ Culture Kit specifically develop..
PU
04/28CHR HANSEN A/Sá : . Hansen launches the next generation of FreshQ« food cultures..
PU
04/28CHR HANSEN A/Sá : . Hansen launches the next generation of FreshQ« food cultures..
PU
More news
Financials
Sales 2021 1 075 M 1 302 M 1 302 M
Net income 2021 868 M 1 051 M 1 051 M
Net Debt 2021 812 M 983 M 983 M
P/E ratio 2021 11,4x
Yield 2021 2,41%
Capitalization 9 869 M 11 954 M 11 949 M
EV / Sales 2021 9,93x
EV / Sales 2022 9,22x
Nbr of Employees 3 286
Free-Float 77,9%
Chart CHR. HANSEN HOLDING A/S
Duration : Period :
Chr. Hansen Holding A/S Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends CHR. HANSEN HOLDING A/S
Short TermMid-TermLong Term
TrendsBearishNeutralBearish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus HOLD
Number of Analysts 12
Average target price 75,74 €
Last Close Price 74,91 €
Spread / Highest target 16,6%
Spread / Average Target 1,11%
Spread / Lowest Target -12,1%
EPS Revisions
Managers and Directors
NameTitle
Mauricio Graber President & Chief Executive Officer
Lise Skaarup Mortensen Chief Financial Officer & Executive Vice President
Dominique Reiniche Chairman
Thomas Schńfer Chief Scientific Officer & Executive VP
Winnie Hojvang BŘgel VP-Compliance & Corporate Communications
Sector and Competitors